期刊文献+

多巴胺受体和脂筏对高血压患者细胞NADPH氧化酶的作用 被引量:2

Dopamine receptor and raft lipids regulate NADPH oxidase activity in hypertensive renal proximal tubule cells
下载PDF
导出
摘要 目的探讨还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NADPH氧化酶即Nox)亚单位在高血压患者肾脏近曲小管细胞中的表达及其活性变化,以及多巴胺受体和脂筏在其中的调节作用。方法细胞分为正常组和高血压组,未经任何药物刺激的两组细胞分别作为正常对照组和高血压对照组,采用葡萄糖浓度梯度超速离心法提取细胞膜的脂筏和非脂筏区蛋白,经Western blot检测Nox亚单位蛋白的表达,光泽精化学发光法动态测定细胞膜Nox的活性。结果多巴胺受体激动剂fenoldopam明显减少gp91phox在正常对照组[(17±3.3)%]和高血压对照组[(20±3.4)%,P<0.05]细胞膜脂筏区域的表达,降低正常对照组p22phox[(15±2.0)%,P<0.05]、p67phox、rac1在脂筏区的表达,但不能减少高血压对照组p22phox、p67phox、rac1蛋白的表达;胆固醇耗竭剂β-CD减少正常对照组gp91phox、p22phox在脂筏区的表达,不能减少高血压对照组Nox亚单位的表达;高血压对照组Nox的基础活性是正常对照组的5倍。结论高血压患者肾脏近曲小管细胞具有较高的Nox亚单位的活性,多巴胺受体和脂筏对Nox亚单位的抑制作用减弱。 Objective To investigate the expression and activity of NADPH oxidase (Nox) subunit in hypertensive renal proximal tubule cells (HT) and the regulatory role of dopamine receptors and lipid boat. Methods Cells were seperated into normotensive group(NT) and hypertensive group (HT), and their respective control group was established by leafing the cells intact. Glucose concentration gradient was used to extract cell membrane lipid rafts and non-lipid rafts region. The expression levels of Nox subunits were detected by Western blot, and NADPH oxidase activity were measured by Lucigenin Chemiluminescence. Results Compared with control group, dopamine receptor agonist of fenoldopam significantly reduced gp91 expression in membrane lipid raft regions both in NT[ (17 ±3.3)%] and in HT[ (20 ±3.4)% , P〈0.05, n=4], also reducedp22[(15±2.0)%, P〈0.05, n=3], p67, racl expression in lipid rafts in NT, but didn't reduce the p22, p67, racl protein expression in HT; Cholesterol depleting agent β-CD reduced gp91, p22 expression in lipid rafts in NT, but didn't reduce Nox expression in the area of lipid rafts of hypertension group; The basic Nox activity was 4-fold higher in HT than in NT. Conclsion Nox subunits expression are significantly high in HT, and the regulatary effect of dopamine receptor and lipid rafts on these expressions are weakened.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第3期211-215,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81070210)
关键词 NADPH氧化酶 多巴胺受体 脂筏 高血压 NADPH oxidase dopamine receptor lipid rafts hypertension
  • 相关文献

参考文献10

  • 1Touyz R M,Schiffrin E L. Reactive oxygen species in vascular biology:implications in hypertension[J].Histochemistry and Cell Biology,2004,(04):339-352.
  • 2Vaziri N D,Rodriguez-Iturbe B. Mechanisms of disease:oxidative stress and inflammation in the pathogenesis of hypertension[J].Nephrology,2006,(10):582-593.
  • 3Han W,Li H,Villar V A. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells[J].Hypertension,2008,(02):481-487.
  • 4Jose P A,Eisner G M,Felder R A. Role of dopamine receptors in the kidney in the regulation of blood pressure[J].Current Opinion in Nephrology and Hypertension,2002,(01):87-92.doi:10.1097/00041552-200201000-00013.
  • 5Hussain T,Lokhandwala M F. Renal dopamine receptors and hypertension[J].Experimental Biology and Medicine,2003,(02):134-142.
  • 6Yang Z,Asico L D,Yu P. D5 dopamine receptor regulation of reactive oxygen species production,NADPH oxidase,and blood pressure[J].American Journal of Physiology-Regulatory Integrative and Comparative Physiology,2006,(01):R96-104.
  • 7Li H,Han W,Villar V A. D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells[J].Hypertension,2009,(06):1054-1061.
  • 8Zeng C,Villar V A,Eisner G M. G protein-coupled receptor kinase 4:role in blood pressure regulation[J].Hypertension,2008,(06):1449-1455.doi:10.1161/HYPERTENSIONAHA.107.096487.
  • 9Allen J A,Halverson-Tamboli R A,Rasenick M M. Lipid raft microdomains and neurotransmitter signalling[J].Nature Reviews Neuroscience,2007,(02):128-140.
  • 10Callera G E,Montezano A C,Yogi A. Vascular signaling through cholesterol-rich domains:implications in hypertension[J].Current Opinion in Nephrology and Hypertension,2007,(02):90-104.doi:10.1097/MNH.0b013e328040bfbd.

同被引文献22

  • 1Ansley D M,Wang B.Oxidative stress and myocardial injury in the diabetic heart[J].J Pathol,2013,229(2):232-41.
  • 2Raedschelders K,Ansley D M,Chen D D.The cellular and mo-lecular origin of reactive oxygen species generation during myocar-dial ischemia and reperfusion[J].Pharmacol Ther,2012,133(2):230-55.
  • 3Gardiner G J,Deffit S N,McLetchie S,et al.A Role for NADPH Oxidase in Antigen Presentation [J].Front Immunol,2013,4:295.
  • 4Drummond G R,Selemidis S,Griendling K K,et al.Combating oxidative stress in vascular disease NADPH oxidases as therapeutic targets[J].Nat Rev Dru-Discov,2011,10(6):453-71.
  • 5Gamkrelidze M,Mamamtavrishvili N,Bejitashvili N,et al.Role of oxidative stress in pathogenesis of atherosclerosis [ J ].Georgian Med News,2008(163):54-7.
  • 6Aristidis S,Nikolaidis M G,Kyparos A,et al.Effects of xanthine oxidase inhibition on oxidative stress and swimming performance in rats[J].Appl Physiol Nutr Metab,2008,33(6):1140-54.
  • 7Pastori D,Carnevale R,Pignatelli P.Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases? [J].In-tern Emerg Med,2014,9(2):123-31.
  • 8Honjo T,Yamaoka-Tojo M,Inoue N.Pleiotropic effects of ARB in vascular metabolism-focusing on atherosclemsis-based cardiovas-cular disease [J].Curr Vasc Pharmacol,2011,9(2):145-52.
  • 9Aoyama T,Minatoguchi S.The effect of ARB on prevention of atherosclerosis [J].Nihon Rinsho,2011,69(1):92-9.
  • 10Patarroyo Aponte M M,Francis G S.Effect of Angiotensin-conver-ting enzyme inhibitors and Angiotensin receptor antagonists in ath-erosclerosis prevention[J].Curr Cardiol Rep,2012,14(4):433-42.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部